logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Serotonin-3 Receptor Antagonist class drugs

    FiltersReset Filters
    6 results

    • akynzeo

      (Netupitant and Palonosetron)
      Helsinn Therapeutics (U.S.), Inc.
      Usage: AKYNZEO is indicated for the prevention of acute and delayed nausea and vomiting in adults undergoing cancer chemotherapy, particularly highly emetogenic regimens. It is used in combination with dexamethasone and consists of palonosetron and netupitant (or fosnetupitant in the injection form).

    • ondansetron

      (Ondansetron)
      Natco Pharma USA LLC
      Usage: Ondansetron tablets are indicated for preventing nausea and vomiting from highly and moderately emetogenic cancer chemotherapy, specific radiation treatments, and postoperative nausea or vomiting.

    • ondansetron hydrochloride

      (Ondansetron Hydrochloride)
      Chartwell RX, LLC.
      Usage: Ondansetron oral solution is indicated for preventing nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy, specific radiotherapy approaches, and postoperative periods.

    • palonosetron

      (Palonosetron)
      NorthStar Rx LLC
      Usage: Palonosetron hydrochloride injection is indicated for preventing acute and delayed nausea and vomiting related to moderately and highly emetogenic cancer chemotherapy in adults and pediatric patients. It also prevents postoperative nausea and vomiting for up to 24 hours after surgery, but routine prophylaxis is not recommended when the risk is low.

    • palonosetron hydrochloride

      (Palonosetron Hydrochloride)
      Eugia US LLC
      Usage: Palonosetron hydrochloride injection is indicated for preventing acute and delayed nausea and vomiting in adults undergoing moderately and highly emetogenic chemotherapy, as well as for preventing postoperative nausea and vomiting. It is also indicated for pediatric patients aged 1 month to under 17 years for chemotherapy-related nausea.

    • sustol

      (granisetron)
      Heron Therapeutics, Inc.
      Usage: SUSTOL is indicated for the prevention of acute and delayed nausea and vomiting in adults undergoing moderately emetogenic chemotherapy (MEC) or anthracycline and cyclophosphamide (AC) regimens, in combination with other antiemetics.